To the full analysis
Buyback calculator for PharmaSGP Holding
PharmaSGP Holding stock: key metrics
PSG.DEPharmaSGP Holding had an operating margin of 23.3% and a return on invested capital (ROIC) of 52.2% in fiscal 2024.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2017 | 85.1% | 28.6% | 22.2% |
| 2018 | 83.0% | 31.9% | 24.3% |
| 2019 | 90.6% | 39.0% | 26.7% |
| 2020 | 90.2% | 25.4% | 16.8% |
| 2021 | 90.1% | 23.6% | 16.4% |
| 2022 | 89.5% | 20.5% | 13.9% |
| 2023 | 90.6% | 24.4% | 16.2% |
| 2024 | 90.9% | 23.3% | 16.4% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2017 | 16.0% | 15.7% | 14.0% |
| 2018 | 17.5% | 18.3% | 16.0% |
| 2019 | 17.5% | 20.3% | 16.1% |
| 2020 | 92.5% | 214.6% | 42.7% |
| 2021 | 48.2% | 25.7% | 9.3% |
| 2022 | 38.4% | 28.7% | 9.3% |
| 2023 | 41.2% | 46.7% | 12.5% |
| 2024 | 61.1% | 52.2% | 17.1% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Aug 2025
- Latest annual report
- Fiscal year 2024, period end 31 Dec 2024
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 30 Apr 2024)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.